Science
Pathogen P. aeruginosa uses protein to limit entry of last-resort antibiotic
Publication: Phys.org - latest science and technology news stories
Author: Not available in collected metadata
Source published: 19/11/2026, 20:20:12 UTC
Briefing created: 19/11/2026, 20:28:13 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 19/11/2026, 20:25:25 UTC.
Briefings
A University of Geneva team discovered that Pseudomonas aeruginosa rapidly blocks imipenem entry via a protein mechanism, a breakthrough for treating critical infections. Published in the Proceedings of the National Academy of Sciences, this finding offers new strategies to counter antibiotic resistance in severe cases.
Key points
- Pseudomonas aeruginosa uses a specific protein to rapidly block imipenem entry into bacterial cells.
- Imipenem is an antibiotic reserved for critical infections, and this discovery opens new counter-resistance avenues.
Context
Bacteria employ various strategies to defend against antibiotics, including destroying drugs, pumping them out, or altering targets. This study provides a simpler mechanism where the bacterium prevents antibiotic entry, a key finding for treating difficult infections.
Limitations
Evidence is limited to a single study published in 2026. The specific protein mechanism and its precise molecular details remain unverified. No clinical trial data or patient outcomes are provided.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 19/11/2026, 20:28:13 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeidmoddacjvlm4k2mw5nz56uptkkmjzj7yccj6yx7jveh6qgethkzu